← Back to headlines
Apogee Therapeutics Secures $1.3 Billion for Zumilokibart Program
Apogee Therapeutics has successfully arranged $1.3 billion in strategic financing to advance its zumilokibart drug development program.
28 May, 18:43 — 28 May, 18:43
Sources
Showing 1 of 1 sources
